A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)
Conditions
- Epithelial Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Cancer
Interventions
- DRUG: BL-B01D1
- DRUG: Liposomal doxorubicin, Paclitaxel or Topotecan
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Collaborators